Correlation Between Ikena Oncology and Adaptive Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Ikena Oncology and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Adaptive Biotechnologies.
Diversification Opportunities for Ikena Oncology and Adaptive Biotechnologies
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ikena and Adaptive is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Adaptive Biotechnologies go up and down completely randomly.
Pair Corralation between Ikena Oncology and Adaptive Biotechnologies
Given the investment horizon of 90 days Ikena Oncology is expected to under-perform the Adaptive Biotechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Ikena Oncology is 4.11 times less risky than Adaptive Biotechnologies. The stock trades about -0.01 of its potential returns per unit of risk. The Adaptive Biotechnologies Corp is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 467.00 in Adaptive Biotechnologies Corp on August 27, 2024 and sell it today you would earn a total of 2.00 from holding Adaptive Biotechnologies Corp or generate 0.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. Adaptive Biotechnologies Corp
Performance |
| Timeline |
| Ikena Oncology |
| Adaptive Biotechnologies |
Ikena Oncology and Adaptive Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and Adaptive Biotechnologies
The main advantage of trading using opposite Ikena Oncology and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.| Ikena Oncology vs. Eliem Therapeutics | Ikena Oncology vs. HCW Biologics | Ikena Oncology vs. Scpharmaceuticals | Ikena Oncology vs. Milestone Pharmaceuticals |
| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world |